申请人:Warner-Lambert Company
公开号:US05834506A1
公开(公告)日:1998-11-10
This invention pertains to improved antiviral activity of 6,6-disubstituted-5,6-dihydropyran-2-ones caused by judicious placement of certain polar substituents at the 3 and/or 6 positions. The same substituents which enhance the cellular activity also diminish cytotoxicity further enhancing the desirable properties of these agents as antivirals.
本发明涉及通过在3和/或6位置聪明地放置某些极性取代基来改善6,6-二取代-5,6-二氢吡喃-2-酮的抗病毒活性。增强细胞活性的相同取代基也减少细胞毒性,进一步增强这些药物作为抗病毒剂的理想性能。